US750351A
(en)
*
|
|
1904-01-26 |
|
Smoke-purifier |
US756552A
(en)
*
|
1898-04-14 |
1904-04-05 |
Robert Adams |
Window-sash.
|
US680835A
(en)
*
|
1900-07-05 |
1901-08-20 |
Joseph A Beamisderfer |
Nut-lock.
|
US2004100A
(en)
|
1934-05-25 |
1935-06-11 |
Carter Loran Everett |
Brush and stubble cutter
|
JPS4916937B1
(es)
|
1970-01-21 |
1974-04-25 |
|
|
JPS4920973B1
(es)
|
1970-05-28 |
1974-05-29 |
|
|
US3823240A
(en)
|
1970-10-06 |
1974-07-09 |
Rhone Poulenc Sa |
Fungicidal hydantoin derivatives
|
JPS4887030U
(es)
|
1972-01-27 |
1973-10-22 |
|
|
US3923994A
(en)
*
|
1973-07-13 |
1975-12-02 |
Smithkline Corp |
Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity
|
GB1472467A
(en)
|
1974-04-19 |
1977-05-04 |
Wyeth John & Brother Ltd |
Thiohydantoins
|
FR2329276A1
(fr)
|
1975-10-29 |
1977-05-27 |
Roussel Uclaf |
Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
|
US3970662A
(en)
|
1975-06-19 |
1976-07-20 |
Sterling Drug Inc. |
4-(3-Nitrophenyl)-2,3,5,6-pyridinetetracarboxylic acid and intermediates
|
DE2614831A1
(de)
|
1976-04-06 |
1977-10-20 |
Bayer Ag |
1,3,4-thiadiazolylderivate, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
|
CA1138334A
(en)
|
1977-10-28 |
1982-12-28 |
Karl Bernauer |
Pharmaceutical preparations containing certain urea derivatives
|
MC1220A1
(fr)
|
1977-10-28 |
1979-07-20 |
Hoffmann La Roche |
Nouveaux derives d'imidazolidine
|
ZA786739B
(en)
|
1977-12-01 |
1980-07-30 |
Wellcome Found |
Hydantoin derivatives and salts thereof,their syntheses,and intermediates,and pharmaceutical formulations
|
EP0004723A1
(en)
|
1978-03-30 |
1979-10-17 |
Beecham Group Plc |
Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
|
FR2449448B1
(fr)
|
1979-02-20 |
1983-05-27 |
Inst Nat Radio Elements |
Composition pharmaceutique comprenant un derive de phenylhydantoine, derives mis en oeuvre et leur preparation
|
FI801184A
(fi)
|
1979-04-24 |
1980-10-25 |
Hoffmann La Roche |
Foerfarande foer framstaellning av imidazolidinderivat
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
NZ197008A
(en)
|
1980-05-22 |
1984-10-19 |
Ici Ltd |
Acylanilide derivatives and pharmaceutical compositions
|
JPS57197268A
(en)
|
1981-05-29 |
1982-12-03 |
Sumitomo Chem Co Ltd |
Substituted phenylhydantoin derivative, its preparation, and herbicide containing the same as active ingredient
|
US4753957A
(en)
*
|
1981-09-28 |
1988-06-28 |
Rohm And Haas Company |
Substituted 2,4-imidazolidinediones and fungicidal compositions
|
DE3382406D1
(de)
|
1982-04-08 |
1991-10-17 |
Shell Int Research |
Neue hydantoine, ihre herstellung und verwendung.
|
US4432987A
(en)
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
ATE28864T1
(de)
*
|
1982-07-23 |
1987-08-15 |
Ici Plc |
Amide-derivate.
|
US4473393A
(en)
|
1982-08-06 |
1984-09-25 |
Buffalo Color Corporation |
Pesticidal thiohydantoin compositions
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
JPS59210083A
(ja)
|
1983-05-13 |
1984-11-28 |
Otsuka Chem Co Ltd |
1,3,4−チアジアゾ−ル−5−オン誘導体、その製造法及び該誘導体を有効成分とする除草剤
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
JPS6092285A
(ja)
|
1983-10-26 |
1985-05-23 |
Shionogi & Co Ltd |
イソオキサゾ−ル系環状尿素類
|
GB8513754D0
(en)
|
1985-05-31 |
1985-07-03 |
Jones T R |
Anti-cancer quinazoline derivatives
|
DE3604042A1
(de)
|
1986-02-08 |
1987-08-13 |
Hoechst Ag |
Imidazolidin(thi)on-derivate, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz
|
US5071773A
(en)
|
1986-10-24 |
1991-12-10 |
The Salk Institute For Biological Studies |
Hormone receptor-related bioassays
|
US5084472A
(en)
*
|
1986-11-04 |
1992-01-28 |
Roussel |
Application of 1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4'-dimethylimidazoline 2,5-dione in the treatment of hormone-dependent cancers other than that of the prostate
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
US4859228A
(en)
|
1987-07-16 |
1989-08-22 |
Ici Americas Inc |
Novel 5-aminomethylene-2,4-imidazolidinediones and 5-aminomethylene-2-thionoimidazolidine-4-ones
|
US5010182A
(en)
|
1987-07-28 |
1991-04-23 |
Chiron Corporation |
DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
|
FR2619381B1
(fr)
|
1987-08-13 |
1989-12-08 |
Roussel Uclaf |
Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation
|
CA1331757C
(en)
|
1988-02-29 |
1994-08-30 |
Janssen Pharmaceutica Naamloze Vennootschap |
5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
|
US5614620A
(en)
|
1988-03-30 |
1997-03-25 |
Arch Development Corporation |
DNA binding proteins including androgen receptor
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
US6307030B1
(en)
|
1988-04-15 |
2001-10-23 |
The University Of North Carolina At Chapel Hill |
Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
|
JPH0219363A
(ja)
|
1988-07-06 |
1990-01-23 |
Fujisawa Pharmaceut Co Ltd |
イミダゾリジン誘導体
|
AU4005289A
(en)
|
1988-08-25 |
1990-03-01 |
Smithkline Beecham Corporation |
Recombinant saccharomyces
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
DE3835168A1
(de)
|
1988-10-15 |
1990-04-19 |
Bayer Ag |
N-aryl-stickstoffheterocyclen, mehrere verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
FR2646437B1
(fr)
|
1989-04-28 |
1991-08-30 |
Transgene Sa |
Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
|
FR2656302B1
(fr)
|
1989-12-22 |
1992-05-07 |
Roussel Uclaf |
Nouveau procede de preparation de l'anandron et derives de l'anandron.
|
FR2693461B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
FR2671348B1
(fr)
|
1991-01-09 |
1993-03-26 |
Roussel Uclaf |
Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
USRE35956E
(en)
|
1991-01-09 |
1998-11-10 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
US5346913A
(en)
|
1992-05-26 |
1994-09-13 |
Rohm And Haas Company |
N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents
|
FR2694290B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
TW521073B
(en)
|
1994-01-05 |
2003-02-21 |
Hoechst Marion Roussel Inc |
New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
|
FR2715402B1
(fr)
|
1994-01-05 |
1996-10-04 |
Roussel Uclaf |
Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
JPH09508125A
(ja)
|
1994-01-21 |
1997-08-19 |
セプラコー,インコーポレイテッド |
光学的純正r−(−)−カソデックスを使用した男性ホルモン依存疾患治療のための方法と組成
|
ATE198743T1
(de)
|
1994-07-29 |
2001-02-15 |
Suntory Ltd |
Imidazolidin-derivate und ihre verwendung
|
FR2725206B1
(fr)
|
1994-09-29 |
1996-12-06 |
Roussel Uclaf |
Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
|
US5656651A
(en)
*
|
1995-06-16 |
1997-08-12 |
Biophysica Inc. |
Androgenic directed compositions
|
BR9610120A
(pt)
*
|
1995-09-07 |
1999-12-21 |
Univ Georgia Res Found |
Composição farmacêutica e processo para aumentar a meia vida de um medicamento em um indivìduo e para melhorar uma condição patológica em um paciente.
|
DE19540027A1
(de)
|
1995-10-27 |
1997-04-30 |
Gruenenthal Gmbh |
Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
|
FR2741346B1
(fr)
|
1995-11-16 |
1997-12-19 |
Roussel Uclaf |
Nouveau procede de preparation de derives phenylimidazolidine
|
FR2741342B1
(fr)
*
|
1995-11-22 |
1998-02-06 |
Roussel Uclaf |
Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
|
EP0876354A1
(en)
|
1995-11-28 |
1998-11-11 |
American Home Products Corporation |
2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives
|
US5554607A
(en)
*
|
1995-11-28 |
1996-09-10 |
American Home Products Corporation |
Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis
|
TW418195B
(en)
*
|
1995-11-28 |
2001-01-11 |
American Home Prod |
2-thioxo-imidazolidin-4-one derivatives
|
FR2742749B1
(fr)
|
1995-12-22 |
1998-02-06 |
Roussel Uclaf |
Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
|
US6489163B1
(en)
|
1996-05-08 |
2002-12-03 |
Board Of Regents, The University Of Texas System |
Ribozyme mediated inactivation of the androgen receptor
|
JP3697320B2
(ja)
|
1996-06-20 |
2005-09-21 |
株式会社日立製作所 |
光ファイバセンサ
|
US5726061A
(en)
|
1996-10-08 |
1998-03-10 |
Smithkline Beechum Corporation |
Method of diagnosing and monitoring colorectal cancer
|
US7053263B2
(en)
|
1996-10-15 |
2006-05-30 |
The Regents Of The University Of California |
Mouse models of human prostate cancer progression
|
US7205437B2
(en)
|
1996-11-27 |
2007-04-17 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
EP0887658B1
(en)
|
1997-06-27 |
2004-08-25 |
EADS Deutschland GmbH |
Radar level gauge
|
US6506607B1
(en)
|
1997-12-24 |
2003-01-14 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
|
WO1999065494A1
(en)
*
|
1998-06-15 |
1999-12-23 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
EP0989122B1
(de)
|
1998-09-22 |
2003-05-21 |
Degussa AG |
Verfahren zur Herstellung von Imidazolidin-2,4-dionen
|
CN1129581C
(zh)
|
1998-09-22 |
2003-12-03 |
山之内制药株式会社 |
氰基苯基衍生物
|
AU1308400A
(en)
|
1998-10-30 |
2000-05-22 |
G.D. Searle & Co. |
Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors
|
US6184249B1
(en)
|
1998-12-18 |
2001-02-06 |
Biophysica, Inc. |
Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
|
US6472415B1
(en)
|
1998-12-18 |
2002-10-29 |
Biophysica, Inc. |
Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
|
AU2847200A
(en)
|
1999-01-27 |
2000-08-18 |
G.D. Searle & Co. |
Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
|
WO2001007048A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
WO2001030764A1
(fr)
*
|
1999-10-22 |
2001-05-03 |
Takeda Chemical Industries, Ltd. |
Alcools de phenyl-1-(1h-imidazol-4-yl) substitues en position 1, procede de preparation et utilisation de ces derniers
|
US6479063B2
(en)
|
1999-12-27 |
2002-11-12 |
Kenneth Weisman |
Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis
|
KR100527290B1
(ko)
*
|
2000-05-31 |
2005-11-09 |
다나베 세이야꾸 가부시키가이샤 |
αLβ2 매개된 세포 부착 저해제
|
US6482829B2
(en)
|
2000-06-08 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
|
EP1337659B1
(en)
|
2000-11-24 |
2006-05-24 |
Osmetech plc |
Detection of infections in liquid samples by detecting fatty acids present in the headspace associated with the liquid sample
|
AU2002221080A1
(en)
|
2000-12-08 |
2002-06-18 |
Masami Kusaka |
Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparingthe same and use thereof
|
WO2002053155A1
(en)
|
2000-12-30 |
2002-07-11 |
Geron Corporation |
Telomerase inhibitor
|
FR2823209B1
(fr)
|
2001-04-04 |
2003-12-12 |
Fournier Lab Sa |
Nouvelles thiohydantoines et leur utilisation en therapeutique
|
RS26604A
(en)
|
2001-10-01 |
2006-12-15 |
Bristol Myers Squibb Company |
Spiro-hydantoin compounds useful as anti-inflamatory agents
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
GB0200283D0
(en)
|
2002-01-08 |
2002-02-20 |
Smithkline Beecham Plc |
Compounds
|
DE60303441T2
(de)
|
2002-02-08 |
2006-09-21 |
Merck & Co., Inc. |
N-biphenylmethylaminocycloalkancarboxamid-derivative
|
DE10218963A1
(de)
|
2002-04-27 |
2003-11-20 |
Aventis Pharma Gmbh |
Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
JP2006512924A
(ja)
|
2002-08-15 |
2006-04-20 |
ジェンザイム・コーポレーション |
脳内皮細胞発現パターン
|
AU2002951247A0
(en)
|
2002-09-06 |
2002-09-19 |
Alchemia Limited |
Compounds that interact with kinases
|
FR2845384B1
(fr)
|
2002-10-04 |
2004-12-31 |
Fournier Lab Sa |
Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique
|
EP1546111A2
(fr)
|
2002-10-04 |
2005-06-29 |
Laboratoires Fournier S.A. |
Composes derives de la 2-thiohydantoine et leur utilisation pour le traitement du diabete
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
DE10322108B4
(de)
*
|
2003-05-09 |
2008-12-11 |
Bayer Schering Pharma Aktiengesellschaft |
Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit
|
JP4664814B2
(ja)
|
2003-06-12 |
2011-04-06 |
中外製薬株式会社 |
イミダゾリジン誘導体
|
CA2526204A1
(en)
|
2003-06-12 |
2004-12-23 |
Novo Nordisk A/S |
Pyridinyl carbamates as hormone-sensitive lipase inhibitors
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
EP1709152A4
(en)
|
2003-12-15 |
2007-11-07 |
Univ California |
MOLECULAR SIGNATURE OF PTEN TUMOR SUPPRESSOR
|
US8034548B2
(en)
*
|
2003-12-19 |
2011-10-11 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
US7173044B2
(en)
|
2004-02-19 |
2007-02-06 |
Solvay Pharmaceuticals B.V. |
Imidazoline derivatives having CB1-antagonistic activity
|
AU2005232526B2
(en)
*
|
2004-02-24 |
2011-06-23 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
MXPA06010542A
(es)
|
2004-03-15 |
2007-03-28 |
Ptc Therapeutics Inc |
Derivados de carbolina tetra-ciclica para la inhibicion de angiogenesis.
|
EP1598343A1
(de)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
EP1621539A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
EP1775289B1
(en)
|
2004-08-03 |
2011-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Novel imidazolidine derivatives
|
EP1790640A4
(en)
|
2004-09-09 |
2009-07-29 |
Chugai Pharmaceutical Co Ltd |
NEW IMIDAZOLIDINE DERIVATIVE AND APPLICATION THEREOF
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
RS52274B2
(sr)
*
|
2005-05-13 |
2018-05-31 |
Univ California |
Jedinjenje diarilhidantoina
|
GB0521373D0
(en)
|
2005-10-20 |
2005-11-30 |
Kudos Pharm Ltd |
Pthalazinone derivatives
|
JP4887030B2
(ja)
|
2005-11-18 |
2012-02-29 |
株式会社日立ハイテクノロジーズ |
荷電粒子線装置
|
CN101032483B
(zh)
|
2006-03-09 |
2011-05-04 |
陈德桂 |
调节雄激素受体活性的乙内酰脲衍生物及其应用
|
HUE027894T2
(en)
*
|
2006-03-27 |
2016-11-28 |
Univ California |
An androgen receptor modulator for the treatment of prostate cancer and androgen receptor related diseases
|
KR101456722B1
(ko)
*
|
2006-03-29 |
2014-10-31 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
디아릴티오히단토인 화합물
|
US8461343B2
(en)
|
2007-03-27 |
2013-06-11 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
PE20121470A1
(es)
|
2007-10-26 |
2012-11-18 |
Univ California |
Compuestos de diarilhidantoina como antagonistas del receptor de androgeno
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
AR072336A1
(es)
|
2007-12-11 |
2010-08-25 |
Theravance Inc |
Derivados de la 3-carboxipropil-aminotetralina, composiciones farmaceuticas que los contienen, procedimiento para su preparacion, intermediarios y su procedimiento de preparacion
|
US20110130296A1
(en)
|
2008-03-14 |
2011-06-02 |
The Regents Of The University Of California |
Multi-gene classifiers and prognostic indicators for cancers
|
EP2400847B1
(en)
|
2009-02-24 |
2014-12-17 |
Medivation Prostate Therapeutics, Inc. |
Specific diarylthiohydantoin compounds
|
US8710086B2
(en)
|
2009-04-09 |
2014-04-29 |
Medivation Technologies, Inc. |
Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
|
WO2011022316A1
(en)
|
2009-08-20 |
2011-02-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Mirnas dysregulated in triple-negative breast cancer
|
WO2011044327A1
(en)
|
2009-10-07 |
2011-04-14 |
Medivation Prostate Therapeutics, Inc. |
Substituted phenylcarbamoyl alkylamino arene compounds and n,n'-bis-arylurea compounds
|
PT2538785T
(pt)
|
2010-02-24 |
2018-05-09 |
Medivation Prostate Therapeutics Llc |
Processos para a síntese de compostos de diariltiohidantoína e diarilhidantoína
|